[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100633285":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":53,"collaborators":57,"id":81,"slug":82,"hasResults":83,"nctId":84,"briefTitle":85,"officialTitle":86,"acronym":26,"eligibilityCriteria":87,"healthyVolunteers":83,"sex":88,"minAge":89,"maxAge":90,"enrollmentInfo":91,"targetDuration":26,"studyType":94,"phases":95,"briefSummary":97,"conditions":98,"keywords":100,"overallStatus":103,"whyStopped":26,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":112,"locationsCount":113},{"fullName":5,"class":6},"Tongji Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Local Surgery","ACTIVE_COMPARATOR","The patients in this arm (group) will undergo local liver surgery according to random allocation.",[13],"Device: Local Liver Surgery",{"label":15,"type":16,"description":17,"interventionNames":18},"Remote Surgery","EXPERIMENTAL","The patients in this arm (group) will undergo remote liver surgery according to random allocation.",[19],"Device: Remote Liver Surgery",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Remote Liver Surgery","The patients in this arm will undergo remote liver surgery.",[15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Local Liver Surgery","The patients in this arm will undergo local liver surgery.",[9],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Peng Zhu, Medicine Doctor","CONTACT","+86-13907170712","zhupeng@medmail.com.cn",[38],{"facility":39,"status":26,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology","Wuhan","Hubei","430030","China","CN",{"type":46,"coordinates":47},"Point",[48,49],114.26667,30.58333,{"lat":49,"lon":48},[52],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},{"type":54,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Chen Xiaoping","Chief of Surgery",[58,60,62,64,66,68,70,73,75,77,79],{"name":59,"class":6},"The First Medical Center of Chinese PLA General Hospital",{"name":61,"class":6},"The First Affiliated Hospital of Anhui Medical University",{"name":63,"class":6},"First Affiliated Hospital of Guangxi Medical University",{"name":65,"class":6},"The Affiliated Hospital Of Guizhou Medical University",{"name":67,"class":6},"Affiliated Hospital of Qinghai University",{"name":69,"class":6},"First Affiliated Hospital of Harbin Medical University",{"name":71,"class":72},"Xinqiao Hospital, Amry Medical University","UNKNOWN",{"name":74,"class":6},"Wuhan TongJi Hospital",{"name":76,"class":6},"Zhujiang Hospital",{"name":78,"class":6},"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",{"name":80,"class":6},"First Affiliated Hospital of Chengdu Medical College","100633285","a-study-about-remote-and-local-liver-surgery-100633285",false,"NCT07524699","A Study About Remote and Local Liver Surgery","Efficacy and Safety of MP1000 System in Remote and Local Liver Surgery: A Prospective, Multicenter, Single-blind, Randomized Controlled Trial","Inclusion Criteria:\n\n1. Age range: 18-75 years old (inclusive), gender not restricted;\n2. BMI: 18-30 Kg\u002Fm2;\n3. Relevant indications for liver surgery;\n4. Physiological condition allows for laparoscopic surgery, and the Iwate score for laparoscopic difficulty of the enrolled patients is ≤ 6;\n5. Willing to cooperate and complete follow-up and related subsequent examinations;\n6. Voluntary to sign the informed consent form;\n7. Indocyanine green 15-minute retention rate (ICG-R15) \\\u003C 15%, and liver function Child-Pugh grade is A.\n\nExclusion Criteria:\n\n1. Patients with severe circulatory system diseases who cannot tolerate surgery;\n2. Pregnant or lactating women;\n3. Patients with a history of epilepsy or mental illness;\n4. Patients with severe allergic constitution and those suspected or diagnosed with alcohol or drug addiction;\n5. Patients who cannot understand the research requirements or who cannot complete the research follow-up;\n6. Patients considered unsuitable to participate in this trial by the researchers.","ALL","18 Years","75 Years",{"count":92,"type":93},148,"ESTIMATED","INTERVENTIONAL",[96],"NA","The goal of this clinical trial is to learn if the robotic surgical system producted by Shenzhen Edge Medical Company has a non-inferior textbook outcome in liver surgery in the field of remote surgery compared to local robotic surgery. It will also learn about the safety of remote liver surgery.\n\nThe main questions are: Does remote liver surgery not lower the textbook outcomes in liver surgery compared to the local robotic surgery? What complications do participants have when taking remote liver surgery? Investigators will compare remote liver surgery to local robotic liver surgery to see if remote liver surgery doesn't lower the textbook outcome in liver surgery.\n\nParticipants will:\n\nUndergo remote or local robotic liver surgery according to the random program; Visit the clinic in 3, 28 and 42 day after surgery for checkups and tests; Keep a diary of their postoperative complications.",[99],"Liver Diseases",[15,101,102],"Liver Surgery","Randomized controlled trial","NOT_YET_RECRUITING","2026-05-13",{"date":106,"type":107},"2026-05-18","ACTUAL",{"date":109,"type":93},"2026-05-16",{"date":111,"type":93},"2028-07-31",{"name":5,"class":6},1]